Breaking News Instant updates and real-time market news.

NKTR

Nektar

$34.06

-1.24 (-3.51%)

20:30
11/11/18
11/11
20:30
11/11/18
20:30

Piper Jaffray bullish on Nektar, more confident in Phase III study success

Following Nektar's updated data from the melanoma cohort at SITC, Piper Jaffray analyst Tyler Van Buren says it is clear that everyone has been "too myopic" by solely focusing on overall response rates. Despite this, the analyst says that it was "encouraging to see" it actually increase to 53% following independent central radiology, and compares well to nivo monotherapy. More importantly, a 24% CR rate is "impressive" at this stage, he contends. The analyst argues that the more durable responses appear to be translating to improved mPFS as it is not nearly reached with the study having about 8 months of median follow-up. Van Buren reiterates an Overweight rating and $125 price target on the shares as he is now incrementally more confident in Phase III study success.

  • 12

    Nov

  • 27

    Nov

NKTR Nektar
$34.06

-1.24 (-3.51%)

11/05/18
HCWC
11/05/18
NO CHANGE
Target $47
HCWC
Neutral
Nektar price target lowered to $47 from $54 at H.C. Wainwright
H.C. Wainwright analyst Debjit Chattopadhyay lowered his price target for Nektar Therapeuticsless than (NKTR) to $47 and keeps a Neutral rating on the shares. While the Phase 3 trial of Opdivo plus NKTR-214 is welcome news, the company faces a crowded frontline renal cell carcinoma treatment landscape and stiff commercial hurdles, Chattopadhyay tells investors in a research note. He believes that unless the NKTR-214 plus Opdivo combination is meaningfully superior to the Opdivo and Yervoy combination, Bristol-Myers (BMY) "may not be willing to muscle the commercial launch, given the cannibalization of its existing franchise."
11/06/18
PIPR
11/06/18
NO CHANGE
PIPR
Nektar abstract references old 50% ORR, says Piper Jaffray
The regular Society for Immunotherapy of Cancer abstract that provides an update of the first line melanoma patient cohort in the ongoing PIVOT-02 trial testing the combination of Nektar Therapeutics's NKTR-214 plus Opdivo was posted, Piper Jaffray analyst Tyler Van Buren tells investors in a research note. He points out that 41 patients were enrolled with 38 evaluable for efficacy and the investigator-assessed objective response rate as of July 12 was 50%. Van Buren says that while is this is what we already knew, it confirms his prior assumption of the 50% response rate floor heading into the Friday afternoon updated data presentation. On Friday, the analyst expects to receive an updated response rate and more details on the quality of response. Finally, no responder has relapsed in this cohort and median duration of response has not been reached, which is promising as we begin to think about the probability of success for the Phase III trial, says the analyst. Shares of Nektar are down 7%, or $2.75, to $37.25 in pre-market trading.
11/08/18
JEFF
11/08/18
NO CHANGE
Target $73
JEFF
Buy
Nektar price target lowered to $73 from $103 at Jefferies
Jefferies analyst David Steinberg lowered his price target for Nektar Therapeutics (NKTR) to $73 after reducing his assumptions for NKTR-214 to reflect a potentially prolonged delay in non-small-cell lung carcinoma. The analyst, however, keeps a Buy rating on the shares following the company's Q3 results. He points out that Nektar's partnership with Bristol-Myers (BMY) as well as its other collaborations are ramping up.
11/08/18
HCWC
11/08/18
NO CHANGE
Target $47
HCWC
Neutral
Nektar shares may have bottomed, says H.C. Wainwright
During last night's Q3 corporate update call, Nektar Therapeutics provided clarity on soon to be initiated Phase 3 programs, with a vital expansion cohort in second line non-small cell lung cancer, H.C. Wainwright analyst Debjit Chattopadhyay tells investors in a research note. While the renal cell carcinoma, bladder, and melanoma studies were telegraphed previously, "clarity was welcome news for the bulls," says Chattopadhyay. However, the analyst adds that RCC and melanoma remain very crowded and that the initiation of triplet studies, if successfully clinically, "would significantly add to the financial toxicity discussion, especially since NKTR-214 is likely to be marketed as a unique medicine." Chattopadhyay thinks the newly defined cohort of approximately 100 second-line NSCLC patients to the ongoing Pivot trial is key to sentiment around the NKTR-214 story during the second half of 2019. He attributes the recent pullback in Nektar shares to disappointment from the preliminary read from the SITC abstract. Nonetheless, with a host of trial initiations and multiple combination updates at disease specific conferences during 2019, the stock may have bottomed, Chattopadhyay writes. However, the analyst says that while the study initiations and data releases should "quell some fears," the data quality "needs a pickup." He keeps a Neutral rating on Nektar with a $47 price target.

TODAY'S FREE FLY STORIES

COP

ConocoPhillips

$65.69

-2.21 (-3.25%)

, SNP

Sinopec

$77.78

-1.96 (-2.46%)

21:01
01/22/19
01/22
21:01
01/22/19
21:01
Periodicals
Breaking Periodicals news story on ConocoPhillips, Sinopec »

Sinopec and…

COP

ConocoPhillips

$65.69

-2.21 (-3.25%)

SNP

Sinopec

$77.78

-1.96 (-2.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

  • 28

    May

ALPN

Alpine Immune Sciences

$5.79

(0.00%)

20:50
01/22/19
01/22
20:50
01/22/19
20:50
Hot Stocks
Alpine Immune Sciences CEO buys 191K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LW

Lamb Weston

$70.75

-0.145 (-0.20%)

20:36
01/22/19
01/22
20:36
01/22/19
20:36
Upgrade
Lamb Weston rating change  »

Lamb Weston upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMB

Kimberly-Clark

$115.15

-1.675 (-1.43%)

, UTX

United Technologies

$111.23

-2.7 (-2.37%)

20:25
01/22/19
01/22
20:25
01/22/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

KMB

Kimberly-Clark

$115.15

-1.675 (-1.43%)

UTX

United Technologies

$111.23

-2.7 (-2.37%)

ABT

Abbott

$71.56

0.13 (0.18%)

CMCSK

Comcast

$0.00

(0.00%)

CMCSA

Comcast

$35.16

-1.05 (-2.90%)

PG

Procter & Gamble

$90.50

-0.89 (-0.97%)

PGR

Progressive

$63.18

-1.24 (-1.92%)

APH

Amphenol

$81.06

-1.41 (-1.71%)

SYF

Synchrony

$26.55

0.27 (1.03%)

WAT

Waters

$203.52

-3.315 (-1.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 24

    Jan

  • 25

    Jan

  • 27

    Jan

  • 30

    Jan

  • 11

    Feb

  • 18

    Feb

  • 03

    Mar

  • 28

    May

TXRH

Texas Roadhouse

$66.00

-1 (-1.49%)

20:23
01/22/19
01/22
20:23
01/22/19
20:23
Downgrade
Texas Roadhouse rating change  »

Texas Roadhouse…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Continental

$83.34

-2.27 (-2.65%)

, JBLU

JetBlue

$17.36

-0.24 (-1.36%)

19:49
01/22/19
01/22
19:49
01/22/19
19:49
Hot Stocks
Normal operations at Newark Airport have resumed after reported drone activity »

Newark International…

UAL

United Continental

$83.34

-2.27 (-2.65%)

JBLU

JetBlue

$17.36

-0.24 (-1.36%)

AAL

American Airlines

$32.75

-1.21 (-3.56%)

LUV

Southwest

$50.54

-1.04 (-2.02%)

DAL

Delta Air Lines

$47.10

-1 (-2.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 24

    Jan

  • 24

    Jan

  • 04

    Mar

PLL

Piedmont Lithium

$7.60

(0.00%)

19:35
01/22/19
01/22
19:35
01/22/19
19:35
Hot Stocks
Piedmont Lithium initiates 25K meter drill program »

Piedmont Lithium Limited…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GSBC

Great Southern Bancorp

$49.85

-0.7 (-1.38%)

19:34
01/22/19
01/22
19:34
01/22/19
19:34
Earnings
Great Southern Bancorp reports preliminary Q4 EPS $1.21, consensus $1.12 »

Reports Q4 NII $44.6M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 13

    Feb

  • 14

    Feb

BAYRY

Bayer

$0.00

(0.00%)

19:08
01/22/19
01/22
19:08
01/22/19
19:08
Periodicals
Bayer requests that CA judge limit evidence in Roundup trial, Reuters says »

Bayer's Monsanto has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLK

BlackRock

$413.28

-6.01 (-1.43%)

19:07
01/22/19
01/22
19:07
01/22/19
19:07
Hot Stocks
BlackRock CEO sells 30.8K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 29

    Jan

  • 11

    Feb

EHTH

eHealth

$45.38

-0.85 (-1.84%)

, ARAY

Accuray

$3.97

0.09 (2.32%)

19:01
01/22/19
01/22
19:01
01/22/19
19:01
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS:…

EHTH

eHealth

$45.38

-0.85 (-1.84%)

ARAY

Accuray

$3.97

0.09 (2.32%)

NAVI

Navient

$10.87

-0.05 (-0.46%)

IBM

IBM

$122.34

-1.49 (-1.20%)

CNMD

Conmed

$66.62

-0.03 (-0.05%)

PUMP

ProPetro Holding

$14.96

-0.49 (-3.17%)

AMTD

TD Ameritrade

$54.96

-0.38 (-0.69%)

TBNK

Territorial Bancorp

$26.90

-0.26 (-0.96%)

APHA

Aphria

$7.07

0.41 (6.16%)

TSE

Trinseo

$48.54

-2.78 (-5.42%)

COF

Capital One

$83.38

-1.62 (-1.91%)

QUOT

Quotient Technology

$10.99

-0.55 (-4.77%)

IBKR

Interactive Brokers

$51.92

-2.82 (-5.15%)

PTCT

PTC Therapeutics

$33.08

-1.245 (-3.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 23

    Jan

  • 23

    Jan

  • 24

    Jan

  • 10

    Feb

  • 11

    Feb

  • 13

    Feb

  • 25

    Feb

  • 27

    Feb

  • 03

    Mar

  • 04

    Mar

  • 18

    May

  • 23

    Jan

  • 25

    Jan

APHA

Aphria

$7.07

0.41 (6.16%)

18:55
01/22/19
01/22
18:55
01/22/19
18:55
Hot Stocks
Green Growth files offer to acquire Aphria »

Green Growth Brands Inc.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOGI

Logitech

$33.69

0.24 (0.72%)

18:42
01/22/19
01/22
18:42
01/22/19
18:42
Hot Stocks
Logitech CEO says 'we had a very strong quarter' »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

WBA

Walgreens Boots Alliance

$71.59

-0.81 (-1.12%)

18:39
01/22/19
01/22
18:39
01/22/19
18:39
Periodicals
Walgreens to pay $269.2M to resolve U.S. fraud suits, Reuters reports »

The U.S. Department of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

SMBC

Southern Missouri Bancorp

$32.22

-0.29 (-0.89%)

18:35
01/22/19
01/22
18:35
01/22/19
18:35
Earnings
Southern Missouri Bancorp sees Q2 adjusted EPS 81c, consensus 72c »

Southern Missouri…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Z

Zillow

$31.41

-2.52 (-7.43%)

18:32
01/22/19
01/22
18:32
01/22/19
18:32
Hot Stocks
Zillow's StreetEasy unveils new Listing Tools platform »

StreetEasyunveiled…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIA

Viacom

$32.44

-0.71 (-2.14%)

, VIAB

Viacom

$29.22

-0.87 (-2.89%)

18:25
01/22/19
01/22
18:25
01/22/19
18:25
Hot Stocks
Viacom to acquire Pluto TV for $340M in cash »

Viacom Inc. announced…

VIA

Viacom

$32.44

-0.71 (-2.14%)

VIAB

Viacom

$29.22

-0.87 (-2.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

  • 05

    Feb

GOOG

Alphabet

$1,070.72

-27.53 (-2.51%)

, GOOGL

Alphabet Class A

$1,078.68

-28.24 (-2.55%)

18:23
01/22/19
01/22
18:23
01/22/19
18:23
Periodicals
Google spent company-record $21.2M on U.S. lobbying in 2018, Reuters says »

Alphabet's Google…

GOOG

Alphabet

$1,070.72

-27.53 (-2.51%)

GOOGL

Alphabet Class A

$1,078.68

-28.24 (-2.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 24

    Jan

  • 04

    Feb

  • 04

    Feb

  • 25

    Feb

  • 03

    Mar

VIA

Viacom

$32.44

-0.71 (-2.14%)

, VIAB

Viacom

$29.22

-0.87 (-2.89%)

18:16
01/22/19
01/22
18:16
01/22/19
18:16
Periodicals
Viacom to buy Pluto TV for $340M in cash, THR reports »

Viacom will pay $340M in…

VIA

Viacom

$32.44

-0.71 (-2.14%)

VIAB

Viacom

$29.22

-0.87 (-2.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

  • 05

    Feb

AZZ

AZZ Inc.

$45.09

-0.67 (-1.46%)

18:13
01/22/19
01/22
18:13
01/22/19
18:13
Earnings
AZZ Inc. sees FY20 EPS $2.25-$2.75, consensus $2.54 »

Sees FY20 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$298.80

-3.46 (-1.14%)

18:13
01/22/19
01/22
18:13
01/22/19
18:13
Hot Stocks
Elon Musk says Tesla Sentry Mode 'coming soon' for cars with Enhanced Autopilot »

Tesla CEO Elon Musk said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

NCOM

National Commerce

$39.07

-0.03 (-0.08%)

18:01
01/22/19
01/22
18:01
01/22/19
18:01
Earnings
National Commerce reports Q4 EPS 51c, consensus 68c »

Reports Q4 NII $43.9M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBM

IBM

$122.34

-1.49 (-1.20%)

18:01
01/22/19
01/22
18:01
01/22/19
18:01
Hot Stocks
IBM says Red Hat acquisition will help accelerate leadership in hybrid cloud »

Says tax was a headwind…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 25

    Feb

  • 03

    Mar

  • 04

    Mar

UAL

United Continental

$83.34

-2.27 (-2.65%)

17:57
01/22/19
01/22
17:57
01/22/19
17:57
Periodicals
United Continental says FAA initiated ground stop for all Newark traffic 

Reported by Bloomberg.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Mar

AQMS

Aqua Metals

$2.16

0.07 (3.35%)

17:55
01/22/19
01/22
17:55
01/22/19
17:55
Hot Stocks
Aqua Metals director Shariq Yosufzai buys 10,000 shares of company stock »

Aqua Metals director…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.